Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease
Clicks: 317
ID: 114260
1998
Treatment of patients with typical cat-scratch disease with oral azithromycin for five days affords significant clinical benefit as measured by total decrease in lymph node volume within the first month of treatment.
| Reference Key |
jw1998theprospective
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bass JW;Freitas BC;Freitas AD;Sisler CL;Chan DS;Vincent JM;Person DA;Claybaugh JR;Wittler RR;Weisse ME;Regnery RL;Slater LN;; |
| Journal | the pediatric infectious disease journal |
| Year | 1998 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
logistic models
adult
female
male
adolescent
middle aged
Child
Prospective Studies
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
anti-bacterial agents / therapeutic use*
azithromycin / therapeutic use*
ultrasonography
pmid:9655532
doi:10.1097/00006454-199806000-00002
j w bass
b c freitas
l n slater
bartonella henselae*
cat-scratch disease / drug therapy*
lymph nodes / diagnostic imaging
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.